Cancer BiologybioRxivPreprint
In vivo CRISPR screening identifies NF1/RASA1/TP53 co-mutations and downstream MEK signaling as a common key mechanism of sinonasal tumorigenesis
Kenny Vu, Sreenivasulu Gunti, Ramya Viswanathan…·Nyall R. London
This study identifies NF1/RASA1/TP53 co-mutations and MEK signaling as key drivers of sinonasal tumorigenesis through in vivo CRISPR screening and drug response testing.
DOI 10.1101/2025.05.19.654661